Trial Profile
Impact of Empagliflozin on Infarct Size and Outcomes Following Primary PCI
Status:
Recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 03 Oct 2016
Price :
$35
*
At a glance
- Drugs Empagliflozin (Primary)
- Indications Cardiovascular disorders
- Focus Therapeutic Use
- 03 Oct 2016 New trial record